Chase Science Co., Ltd (SHE:300941)
China · Delayed Price · Currency is CNY 15.08
-0.21 (-1.37%)
At close: Sep 10, 2026
Chase Science Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,103 | 4,792 | 6,150 | 4,949 | 3,903 | 6,971 | |
Market Cap Growth | -40.87% | -22.08% | 24.25% | 26.82% | -44.02% | - |
Enterprise Value | 2,461 | 4,391 | 6,088 | 4,873 | 3,680 | 6,005 |
Last Close Price | 15.29 | 23.50 | 30.00 | 23.81 | 18.56 | 32.90 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 64.82 | 146.26 | 110.59 | 60.90 | 35.31 | 65.75 |
PS Ratio | 11.90 | 19.43 | 29.37 | 18.95 | 9.88 | 16.58 |
PB Ratio | 2.38 | 3.62 | 4.78 | 3.88 | 3.10 | 5.90 |
P/TBV Ratio | 2.45 | 3.74 | 4.83 | 3.88 | 3.10 | 5.91 |
P/FCF Ratio | - | - | 415.72 | - | 44.03 | 69.00 |
P/OCF Ratio | - | - | 388.19 | - | 43.24 | 68.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 9.43 | 17.81 | 29.08 | 18.65 | 9.31 | 14.29 |
EV/EBITDA Ratio | - | 581.26 | 443.91 | 97.31 | 44.24 | 69.45 |
EV/EBIT Ratio | - | 659.04 | 460.95 | 98.64 | 44.60 | 70.11 |
EV/FCF Ratio | - | - | 411.55 | - | 41.52 | 59.44 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.39 | 0.23 | 0.21 | 0.09 | 0.04 | 0.05 |
Debt / FCF Ratio | - | - | 0.25 | - | 0.04 | 0.05 |
Net Debt / Equity Ratio | -0.52 | -0.88 | -0.88 | -0.91 | -0.97 | -0.98 |
Net Debt / EBITDA Ratio | -109.26 | -153.71 | -82.79 | -23.24 | -14.70 | -13.33 |
Net Debt / FCF Ratio | 21.47 | 48.38 | -76.75 | 578.45 | -13.79 | -11.41 |
Asset Turnover | 0.19 | 0.18 | 0.15 | 0.19 | 0.29 | 0.45 |
Inventory Turnover | 1.93 | 4.00 | 4.70 | 6.56 | 10.91 | 8.28 |
Quick Ratio | 14.30 | 18.19 | 14.33 | 14.50 | 10.76 | 11.55 |
Current Ratio | 21.57 | 18.90 | 14.76 | 14.77 | 10.95 | 11.72 |
Return on Equity (ROE) | 1.75% | 2.61% | 4.30% | 6.44% | 9.05% | 13.01% |
Return on Assets (ROA) | 0.23% | 0.30% | 0.59% | 2.21% | 3.81% | 5.69% |
Return on Invested Capital (ROIC) | 0.76% | 3.74% | 9.77% | 59.39% | 230.14% | 270.20% |
Return on Capital Employed (ROCE) | 0.40% | 0.50% | 1.00% | 3.80% | 6.50% | 7.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.75% | 0.68% | 0.90% | 1.64% | 2.83% | 1.52% |
FCF Yield | -1.01% | -0.50% | 0.24% | -0.04% | 2.27% | 1.45% |
Dividend Yield | 0.53% | 0.35% | 0.47% | 0.59% | 0.92% | 0.47% |
Payout Ratio | 34.76% | 81.48% | 58.40% | 42.68% | 28.41% | 38.62% |
Buyback Yield / Dilution | 51.29% | 0.57% | -1.37% | 0.74% | -0.38% | -32.78% |
Total Shareholder Return | 51.81% | 0.92% | -0.90% | 1.32% | 0.54% | -32.31% |